In light of the recent care of Ebola patients and transmission of Ebola within the U.S., the American Association of Nurse Anesthetists (AANA) continues to monitor the ongoing situation in the U.S. and abroad. Ebola virus disease (EVD) is characterized by a high viral load, high rate of morbidity and mortality when infected, and risk of human-to-human transmission. At the time of this writing, there is no FDA-approved vaccine and treatment for Ebola.1,2
Excellence in care, safety and continuous improvement of care are the hallmarks of the anesthesia profession. Nurse anesthetists may be called upon to care for patients infected with the Ebola virus. The AANA is committed to support Certified Registered Nurse Anesthetists (CRNAs) and the healthcare team to safely deliver patient care, to maintain the health of the nurse anesthetist, and to maintain the safety of families and the community.